Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• TorreLASiegelRLWardEMJemalAGlobal cancer incidence and mortality rates and trends – an updateCancer Epidemiol Biomarkers Prev2016251162726667886
   PubMed Web of Science ®Google Scholar
• PoonDAndersonBOChenLTManagement of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009Lancet Oncol200910111111111819880065
   PubMed Web of Science ®Google Scholar
• ShariffMICoxIJGomaaAIHepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeuticsExpert Rev Gastroenterol Hepatol20093435336719673623
   PubMedGoogle Scholar
• BefelerASDi BisceglieAMHepatocellular carcinoma: diagnosis and treatmentGastroenterology200212261609161912016426
   PubMed Web of Science ®Google Scholar
• BruixJShermanMAmerican Association for the Study of Liver DiseasesManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
   PubMed Web of Science ®Google Scholar
• Juarez-HernándezEMotola-KubaDChávez-TapiaNCUribeMBarbero BecerraVBiomarkers in hepatocellular carcinoma: an overviewExpert Rev Gastroenterol Hepatol201711654955828347162
   PubMed Web of Science ®Google Scholar
• LouJZhangLLvSZhangCJiangSBiomarkers for hepatocellular carcinomaBiomark Cancer2017919
   PubMedGoogle Scholar
• FarinatiFMarinoDDe GiorgioMDiagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?Am J Gastroenterol2006101352453216542289
   PubMed Web of Science ®Google Scholar
• WitjesCDvan AaltenSMSteyerbergEWRecently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysisHepatol Int201371596423519638
   PubMed Web of Science ®Google Scholar
• BertinoGArdiriAMalaguarneraMMalaguarneraGBertinoNCalvagnoGSHepatocellualar carcinoma serum markersSemin Oncol201239441043322846859
   PubMed Web of Science ®Google Scholar
• Van HeesSMichielsenPVanwolleghemTCirculating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinomaWorld J Gastroenterol201622378271828227729734
   PubMed Web of Science ®Google Scholar
• LeerapunASuravarapuSVBidaJPThe utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral populationClin Gastroenterol Hepatol200753394402 quiz 26717368240
   PubMed Web of Science ®Google Scholar
• CavigliaGPAbateMLPetriniEGaiaSRizzettoMSmedileAHighly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detectionHepatol Res2016463E130E13526082262
   PubMed Web of Science ®Google Scholar
• ZhuRYangJXuLDiagnostic performance of des-γ-carboxy prothrombin for hepatocellular carcinoma: a meta-analysisGastroenterol Res Pract2014201452931425165471
   PubMed Web of Science ®Google Scholar
• PotéNCauchyFAlbuquerqueMPerformance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvas-cular invasionJ Hepatol201562484885425450201
   PubMed Web of Science ®Google Scholar
• SoyemiOMOtegbayoJAOlaSOAkereASoyemiTComparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinomaBMC Res Notes2012540322856336
   PubMedGoogle Scholar
• ZhangJShaoCZhouQZhuYZhuJTuCDiagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: a meta-analysisMol Clin Oncol2015351165117126623071
   PubMedGoogle Scholar
• HongYLongJLiHAn analysis of immunoreactive signatures in early stage hepatocellular carcinomaEBioMedicine20152543844626137588
   PubMed Web of Science ®Google Scholar
• Ministry of Health of the People’s Republic of ChinaDiagnosis, management, and treatment of hepatocellular carcinoma (V2011)Journal of Clinical Hepatology20111111411159
   Google Scholar
• Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Infectious Diseases, Chinese Medical AssociationThe guideline of prevention and treatment for chronic hepatitis B: a 2015 updateChinese Journal of Hepatology20152388890526739464
   PubMedGoogle Scholar
• EfronBTibshiraniRImprovements on cross-validation: the 632+ bootstrap methodJ Am Stat Assoc199792438548560
   Web of Science ®Google Scholar
• R Core Team [homepage on the Internet]R: A language and environment for statistical computingViennaR Foundation for Statistical Computing2014 Available from: http://www.R-project.org/Accessed February 05, 2018
   Google Scholar
• ErtleJMHeiderDWichertMA combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinomaDigestion201387212113123406785
   PubMed Web of Science ®Google Scholar
• YuRDingSTanWPerformance of protein induced by vitamin K absence or antagonist-II (PIVKA-II) for hepatocellular carcinoma screening in Chinese populationHepat Mon2015157e2880626300931
   PubMed Web of Science ®Google Scholar
• LeeSRhimHKimYSKangTWSongKDPost-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinomaLiver Int201636458058726503910
   PubMed Web of Science ®Google Scholar
• JiJWangHLiYDiagnostic evaluation of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatitis B virus-related hepa-tocellular carcinoma in China: a large-scale, multicentre studyPLoS One2016114e015322727070780
   PubMed Web of Science ®Google Scholar
• HuBTianXSunJMengXEvaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysisInt J Mol Sci20131412235592358024317431
   PubMed Web of Science ®Google Scholar
• LimTSKim doYHanKHCombined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patientsScand J Gastroenterol201651334435326340708
   PubMed Web of Science ®Google Scholar
• ParkSJJangJYJeongSWUsefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinomaMedicine (Baltimore)20179611e581128296720
   PubMed Web of Science ®Google Scholar
• SongPTangQFengXTangWBiomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinomaScand J Clin Lab Invest Suppl2016245S70S7627438343
   PubMedGoogle Scholar
• ToyodaHKumadaTTadaTSoneYKaneokaYMaedaATumor markers for hepatocellular carcinoma: simple and significant predictors of outcome in patients with HCCLiver Cancer20154212613626020034
   PubMed Web of Science ®Google Scholar
• YamamotoKImamuraHMatsuyamaYSignificance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomyAnn Surg Oncol200916102795280419669841
   PubMed Web of Science ®Google Scholar
• TadaTKumadaTToyodaHRelationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinomaLiver Int200525484885315998436
   PubMed Web of Science ®Google Scholar
• WestJCardTRAithalGPFlemingKMRisk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort studyAliment Pharmacol Ther201745798399028144999
   PubMed Web of Science ®Google Scholar
• MairRDValenzuelaAHaNBIncidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologiesClin Gastroenterol Hepatol201210121412141722902757
   PubMed Web of Science ®Google Scholar
• VelázquezRFRodríguezMNavascuésCAProspective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosisHepatology200337352052712601348
   PubMed Web of Science ®Google Scholar
• DavilaJAMorganRORichardsonPADuXLMcGlynnKAEl-SeragHBUse of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United StatesHepatology201052113214120578139
   PubMed Web of Science ®Google Scholar
• PochaCDieperinkEMcMakenKAKnottAThurasPHoSBSurveillance for hepatocellular cancer with ultrasonography vs. computed tomography – a randomised studyAliment Pharmacol Ther201338330331223750991
   PubMed Web of Science ®Google Scholar
• SimmonsOFetzerDTYokooTPredictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosisAliment Pharmacol Ther201745116917727862091
   PubMed Web of Science ®Google Scholar
• SnowbergerNChinnakotlaSLepeRMAlpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosisAliment Pharmacol Ther20072691187119417944733
   PubMed Web of Science ®Google Scholar